Escape Bio website homepage
January 4, 2023 11:07 AM ESTUpdated 03:53 PM
Startups

'Sor­ry, Es­cape Bio closed': A neu­rode­gen­er­a­tive up­start ex­its bid to ri­val Bio­gen-De­nali

Kyle LaHucik

Senior Reporter

A neu­rode­gen­er­a­tive dis­ease-fo­cused biotech that was at­tempt­ing to go up against the bil­lion-dol­lar pair­ing of Bio­gen and De­nali has shut­tered, End­points News has learned …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER
TRENDING NOW

Trump names Johns Hop­kins re­searcher Mar­ty Makary to lead the FDA; al­so names CDC, Sur­geon Gen­er­al picks

FDA ap­proves Bridge­Bio's heart dis­ease drug, set­ting up com­pe­ti­tion with Pfiz­er, Al­ny­lam

Drug or bi­o­log­ic? An Eli Lil­ly law­suit could im­pact weight loss drug com­pounders

Sur­round­ed by AI bio gi­ants, tiny start­up Nabla Bio makes de no­vo an­ti­bod­ies look more like drugs 

Pa­tient dies in Neu­ro­gene's Rett syn­drome study

sponsored

Are pro­grams with com­pound­ed GLP-1s safe for your pop­u­la­tion?

A service from the Financial Times